ID

15718

Description

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry; ODM derived from: https://clinicaltrials.gov/show/NCT02362659

Link

https://clinicaltrials.gov/show/NCT02362659

Keywords

Versions (1)
  1. 6/9/16 6/9/16 -
Uploaded on

June 9, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-valvular Atrial Fibrillation NCT02362659

English

Eligibility Non-valvular Atrial Fibrillation NCT02362659

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of non-valvular atrial fibrillation during hospitalization.
Description

Atrial Fibrillation | Mitral Valve | Hospitalization

Data type

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0026264
UMLS CUI [3]
C0019993
preexisting atrial fibrillation.
Description

Atrial Fibrillation Pre-existing

Data type

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C2347662
successful all-comer percutaneous coronary intervention:
Description

Percutaneous Coronary Intervention

Data type

boolean

Alias
UMLS CUI [1]
C1532338
procedural success is defined as a reduction of residual luminal diameter stenosis to <50% without in-hospital death, ami or the need for emergency cabg.
Description

Stenosis | Vessel lumen diameter reduction | Acute myocardial infarction | Emergency CABG

Data type

boolean

Alias
UMLS CUI [1]
C1261287
UMLS CUI [2]
C1443265
UMLS CUI [3]
C0155626
UMLS CUI [4]
C1532296
over 18 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
able to provide written informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
atrial fibrillation due to reversible causes (e.g., thyrotoxicosis, pericarditis)
Description

Atrial Fibrillation Due to Thyrotoxicosis | Atrial Fibrillation Due to Pericarditis

Data type

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0040156
UMLS CUI [2,1]
C0004238
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0031046
valvular atrial fibrillation secondary to severe mitral stenosis or prosthetic heart valve
Description

Mitral Valve Atrial Fibrillation Secondary to Mitral Valve Stenosis Severe | Mitral Valve Atrial Fibrillation Secondary to Heart Valve Prosthesis

Data type

boolean

Alias
UMLS CUI [1,1]
C0026264
UMLS CUI [1,2]
C0004238
UMLS CUI [1,3]
C0175668
UMLS CUI [1,4]
C0026269
UMLS CUI [1,5]
C0205082
UMLS CUI [2,1]
C0026264
UMLS CUI [2,2]
C0004238
UMLS CUI [2,3]
C0175668
UMLS CUI [2,4]
C0018825
women who are of childbearing potential treatment with other investigational drugs or devices within 30 days before enrolment or planned use of investigational drugs or devices during the study
Description

Childbearing Potential | Therapeutic procedure Investigational New Drugs Other | Therapeutic procedure Investigational Medical Device Other

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C0205394
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C2346570
UMLS CUI [3,3]
C0205394
life expectancy <12 months due to non-cardiac comorbidities
Description

Life Expectancy Due to Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0009488
active alcohol, drug abuse, psychosocial reasons making study participation impractical
Description

Study Subject Participation Status Limited | Substance Use Disorders | psychosocial aspects

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0439801
UMLS CUI [2]
C0038586
UMLS CUI [3]
C0243156
severe renal insufficiency (calculated creatinine clearance < 30 ml/min) or dialysis
Description

Renal Insufficiency Severe | Creatinine clearance measurement | Dialysis procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0373595
UMLS CUI [3]
C0011946
clinically overt stroke within the last 3 months
Description

Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0038454
known hypersensitivity or contraindication to aspirin, clopidogrel, prasugrel, ticagrelor, dabigatran, rivaroxaban, apixaban, edoxaban or warfarin
Description

Hypersensitivity Aspirin | Medical contraindication Aspirin | Hypersensitivity clopidogrel | Medical contraindication clopidogrel | Hypersensitivity prasugrel | Medical contraindication prasugrel | Hypersensitivity Ticagrelor | Medical contraindication Ticagrelor | Hypersensitivity dabigatran | Medical contraindication dabigatran | Hypersensitivity rivaroxaban | Medical contraindication rivaroxaban | Hypersensitivity apixaban | Medical contraindication apixaban | Hypersensitivity edoxaban | Medical contraindication edoxaban | Hypersensitivity Warfarin | Medical contraindication Warfarin

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0004057
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0004057
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0070166
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C1620287
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C1620287
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C1999375
UMLS CUI [8,1]
C1301624
UMLS CUI [8,2]
C1999375
UMLS CUI [9,1]
C0020517
UMLS CUI [9,2]
C2348066
UMLS CUI [10,1]
C1301624
UMLS CUI [10,2]
C2348066
UMLS CUI [11,1]
C0020517
UMLS CUI [11,2]
C1739768
UMLS CUI [12,1]
C1301624
UMLS CUI [12,2]
C1739768
UMLS CUI [13,1]
C0020517
UMLS CUI [13,2]
C1831808
UMLS CUI [14,1]
C1301624
UMLS CUI [14,2]
C1831808
UMLS CUI [15,1]
C0020517
UMLS CUI [15,2]
C2975435
UMLS CUI [16,1]
C1301624
UMLS CUI [16,2]
C2975435
UMLS CUI [17,1]
C0020517
UMLS CUI [17,2]
C0043031
UMLS CUI [18,1]
C1301624
UMLS CUI [18,2]
C0043031
Back to the top of the page

Similar models

Eligibility Non-valvular Atrial Fibrillation NCT02362659

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Atrial Fibrillation | Mitral Valve | Hospitalization
Item
diagnosis of non-valvular atrial fibrillation during hospitalization.
boolean
C0004238 (UMLS CUI [1])
C0026264 (UMLS CUI [2])
C0019993 (UMLS CUI [3])
Atrial Fibrillation Pre-existing
Item
preexisting atrial fibrillation.
boolean
C0004238 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
Percutaneous Coronary Intervention
Item
successful all-comer percutaneous coronary intervention:
boolean
C1532338 (UMLS CUI [1])
Stenosis | Vessel lumen diameter reduction | Acute myocardial infarction | Emergency CABG
Item
procedural success is defined as a reduction of residual luminal diameter stenosis to <50% without in-hospital death, ami or the need for emergency cabg.
boolean
C1261287 (UMLS CUI [1])
C1443265 (UMLS CUI [2])
C0155626 (UMLS CUI [3])
C1532296 (UMLS CUI [4])
Age
Item
over 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed consent
Item
able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Atrial Fibrillation Due to Thyrotoxicosis | Atrial Fibrillation Due to Pericarditis
Item
atrial fibrillation due to reversible causes (e.g., thyrotoxicosis, pericarditis)
boolean
C0004238 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0040156 (UMLS CUI [1,3])
C0004238 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0031046 (UMLS CUI [2,3])
Mitral Valve Atrial Fibrillation Secondary to Mitral Valve Stenosis Severe | Mitral Valve Atrial Fibrillation Secondary to Heart Valve Prosthesis
Item
valvular atrial fibrillation secondary to severe mitral stenosis or prosthetic heart valve
boolean
C0026264 (UMLS CUI [1,1])
C0004238 (UMLS CUI [1,2])
C0175668 (UMLS CUI [1,3])
C0026269 (UMLS CUI [1,4])
C0205082 (UMLS CUI [1,5])
C0026264 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
C0175668 (UMLS CUI [2,3])
C0018825 (UMLS CUI [2,4])
Childbearing Potential | Therapeutic procedure Investigational New Drugs Other | Therapeutic procedure Investigational Medical Device Other
Item
women who are of childbearing potential treatment with other investigational drugs or devices within 30 days before enrolment or planned use of investigational drugs or devices during the study
boolean
C3831118 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C2346570 (UMLS CUI [3,2])
C0205394 (UMLS CUI [3,3])
Life Expectancy Due to Comorbidity
Item
life expectancy <12 months due to non-cardiac comorbidities
boolean
C0023671 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Study Subject Participation Status Limited | Substance Use Disorders | psychosocial aspects
Item
active alcohol, drug abuse, psychosocial reasons making study participation impractical
boolean
C2348568 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0038586 (UMLS CUI [2])
C0243156 (UMLS CUI [3])
Renal Insufficiency Severe | Creatinine clearance measurement | Dialysis procedure
Item
severe renal insufficiency (calculated creatinine clearance < 30 ml/min) or dialysis
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
Cerebrovascular accident
Item
clinically overt stroke within the last 3 months
boolean
C0038454 (UMLS CUI [1])
Hypersensitivity Aspirin | Medical contraindication Aspirin | Hypersensitivity clopidogrel | Medical contraindication clopidogrel | Hypersensitivity prasugrel | Medical contraindication prasugrel | Hypersensitivity Ticagrelor | Medical contraindication Ticagrelor | Hypersensitivity dabigatran | Medical contraindication dabigatran | Hypersensitivity rivaroxaban | Medical contraindication rivaroxaban | Hypersensitivity apixaban | Medical contraindication apixaban | Hypersensitivity edoxaban | Medical contraindication edoxaban | Hypersensitivity Warfarin | Medical contraindication Warfarin
Item
known hypersensitivity or contraindication to aspirin, clopidogrel, prasugrel, ticagrelor, dabigatran, rivaroxaban, apixaban, edoxaban or warfarin
boolean
C0020517 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0070166 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C1620287 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C1620287 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C1999375 (UMLS CUI [7,2])
C1301624 (UMLS CUI [8,1])
C1999375 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C2348066 (UMLS CUI [9,2])
C1301624 (UMLS CUI [10,1])
C2348066 (UMLS CUI [10,2])
C0020517 (UMLS CUI [11,1])
C1739768 (UMLS CUI [11,2])
C1301624 (UMLS CUI [12,1])
C1739768 (UMLS CUI [12,2])
C0020517 (UMLS CUI [13,1])
C1831808 (UMLS CUI [13,2])
C1301624 (UMLS CUI [14,1])
C1831808 (UMLS CUI [14,2])
C0020517 (UMLS CUI [15,1])
C2975435 (UMLS CUI [15,2])
C1301624 (UMLS CUI [16,1])
C2975435 (UMLS CUI [16,2])
C0020517 (UMLS CUI [17,1])
C0043031 (UMLS CUI [17,2])
C1301624 (UMLS CUI [18,1])
C0043031 (UMLS CUI [18,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial